Food and Behaviour Research

Donate Log In

FAB Research Webinar - Nutrition for ADHD and Neurodiverse Minds - Book Here

  

Omega-3 and Schizophrenia - Research

Bozzatello P et al 2021 - Mental Health in Childhood and Adolescence: The Role of Polyunsaturated Fatty Acids
Bozzatello et al 2019 - Polyunsaturated Fatty Acids: What is Their Role in Treatment of Psychiatric Disorders?
Firth et al 2019 - The efficacy and safety of nutrient supplements in the treatment of mental disorders
Chang & Su 2019 - Nutrition and immunology in mental health: Precision medicine and integrative approaches to address unmet clinical needs in psychiatric treatments
Firth et al 2018 - Adjunctive nutrients in first-episode psychosis: A systematic review of efficacy, tolerability and neurobiological mechanisms.
Hoenders et al 2018 - Natural Medicines for Psychotic Disorders: A Systematic Review
Agostoni et al 2017 - The Role of Omega-3 Fatty Acids in Developmental Psychopathology: A Systematic Review on Early Psychosis, Autism, and ADHD.
Marx et al 2017 - Nutritional psychiatry: the present state of the evidence.
Maekawa et al 2017 - Polyunsaturated fatty acid deficiency during neurodevelopment in mice models the prodromal state of schizophrenia through epigenetic changes in nuclear receptor genes
Qiao et al 2017 - Effects of Omega-3 in the treatment of violent schizophrenia patients.
Underwood 2017 - Omega-3 fatty acids to prevent psychosis: the importance of replication (NEURAPRO trial)
McGorry et al 2017 - Effect of Omega-3 PUFA in Young People at Ultrahigh Risk for Psychotic Disorders: The NEURAPRO RCT
Kane & Correll 2017 - Omega-3 Polyunsaturated Fatty Acids to Prevent Psychosis - The Importance of Replication Studies
Tesei et al 2016 - The potential relevance of DHA and EPA to childhood neuropsychiatric disorders.
Bozzatello et al 2016 - Supplementation with Omega-3 Fatty Acids in Psychiatric Disorders: A Review of Literature Data.
Pawelczyk et al 2016 - Association between PUFA consumption and the transition to psychosis in ultra-high risk individuals
Pawelczyk et al 2016 - A randomized controlled study of supplementation with omega-3 PUFA in first episode schizophrenia
Amminger et al 2015 - Longer-term outcome in the prevention of psychotic disorders by the Vienna omega-3 study.
Zaalberg 2015 - Nutrition, Neurotoxicants and Aggressive Behaviour
Patrick & Ames, 2015 - Vitamin D and omega-3 control serotonin synthesis and action, part 2: relevance for ADHD, bipolar, schizophrenia, and impulsive behavior.
Sarris et al 2015 - Nutritional medicine as mainstream in psychiatry
Arroll et al, 2014 - Nutritional interventions for the adjunctive treatment of schizophrenia
Schimamoto et al, 2014 - Functional characterization of FABP3, 5 and 7 gene variants identified in schizophrenia and autism spectrum disorder
Mischoulon & Freeman 2013 - Omega-3 fatty acids in psychiatry
Politi et al 2011 - Randomized Placebo-Controlled Trials of Omega-3 Polyunsaturated Fatty Acids in Psychiatric Disorders: a Review of Current Literature
Harper KN et al 2011 - Maternal serum docosahexaenoic acid and schizophrenia spectrum disorders in adult offspring
De Souza et al 2011 - Effects of maternal malnutrition and postnatal nutritional rehabilitation on brain fatty acids, learning, and memory
Sethom et al 2010 - PUFA deficits associated with psychotic state in schizophrenia
Hedelin et al 2010 - Dietary intake of fish, omega-3, omega-6 PUFA and vitamin D and psychotic-like symptoms in women from the general population.
Amminger et al 2010 - Long-chain omega-3 for prevention of psychosis: RCT
Fedorova et al 2009 - Deficit in prepulse inhibition in mice caused by dietary n-3 fatty acid deficiency.
Brown & Susser 2008 - Prenatal nutritional deficiency and risk of adult schizophrenia
Berger et al 2008 - Ethyl-EPA in first-episode psychosis. A 1H-MRS study
Rapoport 2008 - Brain AA and DHA cascades are selectively altered by drugs, diet and disease.
Richardson 2008 - Omega-3 Fatty acids and Mood: The Devil is in the Detail
Hallahan and Garland 2007 - Essential fatty acids and mental health (editorial)
Mazza et al 2007 - Omega-3 and antioxidants in neurological and psychiatric diseases: an overview.
Freeman et al. 2006 - Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry
Joy et al 2006 - Polyunsaturated fatty acid supplementation for schizophrenia
Mahadik et al 2006 - Prevention of oxidative stress and improved clinical outcome by adjunctive use of antioxidants and omega-3 in schizophrenia.
Saugstad 2006 - Are neurodegenerative disorders and psychotic manifestations avoidable with adequate dietary omega-3?
Vaddadi 2006 - Essential fatty acids and mental illness.
Vaddadi et al 2006 - Tardive dyskinesia and essential fatty acids
du Bois et al 2005 - Membrane phospholipid composition, alterations in neurotransmitter systems and schizophrenia.
Peet 2004 - International variations in schizophrenia outcome and depression prevalence in relation to national diet
Peet 2003 - EPA in the treatment of schizophrenia and depression: rationale and preliminary double-blind clinical trial results.
Raine et al 2003 - Effects of Environmental Enrichment at Ages 3-5 Years on Schizotypal Personality and Antisocial Behavior at Ages 17 and 23 Years
Cunnane & Crawford - 2003 - Survival of the fattest: fat babies were the key to evolution of the large human brain.
Richardson 2003 - Omega 3 fatty acids in behaviour, cognition and mood
Peet & Horrobin 2002 - A dose-ranging study of EPA treatment in schizophrenia